Suven‘s focus is on drug discovery through partnerships with pharma giants, while MTAR is looking to grow on the back of the precision engineering needs of multinational companies, especially in the energy sector
MTAR gears up to meet growing demand from global energy giants
About 40 years ago, P. Ravindra Reddy had a choice between joining a private sector firm that offered him 40 times the salary he was then earning or becoming an entrepreneur.
Click here to read more...
Click here to see all of Mint’s coverage on the WEF India summit
Collaborative strategy for drug discovery
In March 1989, in the early stages of his 20 years in India as an entrepreneur, Suven Lifesciences Ltd chairman and chief executive officer Venkat Jasti set himself the goal of discovering new drugs.
Click here to read more...